Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × Bevacizumab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 104 Carcinoma, Hepatocellular 59 Ovarian Neoplasms 56 Carcinoma, Non-Small-Cell Lung 36 Neoplasms 31 Fallopian Tube Neoplasms 25 Colonic Neoplasms 21 Endometrial Neoplasms 19 Breast Neoplasms 19 Brain Neoplasms 18 Neoplasm Metastasis 15 Glioblastoma 15 Uterine Cervical Neoplasms 14 Stomach Neoplasms 14 Rectal Neoplasms 13 Lung Neoplasms 12 Liver Neoplasms 11 Triple Negative Breast Neoplasms 10 Melanoma 10 Colorectal Cancer Metastatic 8 Carcinoma, Renal Cell 8 Recurrence 7 Carcinoma, Ovarian Epithelial 7 Advanced Solid Tumors 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Biliary Tract Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Gastrointestinal Neoplasms 5

Interventions

Dexamethasone 221 Lenalidomide 138 daratumumab 118 Bortezomib 89 pomalidomide 79 Calcium Dobesilate 71 carfilzomib 68 Cyclophosphamide 65 Specimen Handling 37 Biopsy 37 belantamab mafodotin 36 fludarabine 33 isatuximab 31 Magnetic Resonance Spectroscopy 31 dexamethasone acetate 29 dexamethasone 21-phosphate 29 auricularum 28 Melphalan 28 talquetamab 27 ixazomib 24 iberdomide 22 elotuzumab 19 selinexor 17 fludarabine phosphate 16 Whole-Body Irradiation 12 X-Rays 11 Stem Cell Transplantation 11 tocilizumab 10 Standard of Care 10 venetoclax 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡